Alprazolam vs Buspirone

Alprazolam provides rapid anxiety relief, typically within 15–30 minutes of oral administration, making it effective for acute anxiety episodes and panic attacks. It is FDA-approved for generalized anxiety disorder and panic disorder ^[1]. However, its efficacy diminishes with chronic use as tolerance develops, and it does not treat the underlying anxiety disorder. Buspirone takes 2–4 weeks to reach full therapeutic effect, similar to antidepressants, and is FDA-approved for generalized anxiety disorder ^[2]. It does not work for acute anxiety episodes or panic attacks. For sustained treatment of GAD, clinical trials show buspirone is comparable to benzodiazepines in efficacy over 4–8 weeks, with response rates of 50–60% ^[3]. Buspirone does not cause tolerance, and its effects are maintained with long-term use. Importantly, buspirone is not effective for panic disorder, social anxiety disorder, or OCD, where alprazolam or SSRIs are preferred ^[4]. Current clinical guidelines recommend buspirone or SSRIs/SNRIs as first-line for GAD, with benzodiazepines reserved for short-term or adjunctive use.

The side-effect profiles differ dramatically. Alprazolam causes sedation (40–75%), cognitive impairment, psychomotor slowing, and potential respiratory depression ^[1]. The most serious concern is dependence: physical dependence can develop within 2–4 weeks of regular use, and withdrawal can be severe, including seizures if discontinued abruptly. Alprazolam has significant abuse potential (Schedule IV controlled substance) and contributes to overdose deaths, particularly when combined with opioids ^[3]. Buspirone's side effects are generally mild: dizziness (12%), nausea (8%), headache (6%), and nervousness (5%) ^[2]. Crucially, buspirone has no abuse potential, no withdrawal syndrome, no sedation, and no cognitive impairment. It does not impair driving or psychomotor performance ^[4]. Buspirone does not potentiate the effects of alcohol. A limitation is that patients who have previously taken benzodiazepines may perceive buspirone as ineffective because they expect the immediate, noticeable relief that benzodiazepines provide — the absence of a "high" is a feature, not a flaw.

Both medications are available as inexpensive generics. Generic alprazolam 0.5 mg (30 tablets) costs $4–10 ^[1]. Generic buspirone 10 mg (60 tablets for twice-daily dosing) costs $4–15 ^[2]. Both are covered by most insurance plans at the lowest copay tier. Brand-name Xanax and BuSpar cost significantly more but are rarely prescribed.

Alprazolam is taken 2–3 times daily for GAD (0.25–0.5 mg per dose) or as needed for panic attacks, with doses up to 4 mg/day for panic disorder ^[1]. This frequent dosing and as-needed use pattern can be both a convenience (flexibility) and a drawback (inconsistent coverage). Buspirone is taken 2–3 times daily at 5–15 mg per dose (total 15–60 mg/day), and must be taken consistently — it does not work on an as-needed basis ^[2]. Both are taken orally. Alprazolam comes in 0.25, 0.5, 1, and 2 mg tablets and an extended-release formulation (Xanax XR) ^[3]. Buspirone is available in 5, 7.5, 10, 15, and 30 mg tablets. Neither requires food for absorption, though buspirone should be taken consistently with or without food (not alternating). Alprazolam requires careful tapering when discontinuing (reduce by no more than 0.5 mg every 3 days) to prevent withdrawal seizures.

Buspirone is the preferred long-term choice for generalized anxiety disorder due to its lack of dependence potential, absence of cognitive impairment, no withdrawal syndrome, and sustained efficacy without tolerance ^[2][4]. Current guidelines from the APA and ACP recommend buspirone or SSRIs/SNRIs as first-line pharmacotherapy for GAD, with benzodiazepines reserved for short-term adjunctive use only ^[3]. Alprazolam may be appropriate for short-term management of acute severe anxiety, panic attacks (where buspirone is ineffective), bridge therapy while waiting for buspirone or an SSRI to take effect, or situational anxiety with careful limits on duration ^[1]. Patients with a history of substance use disorder should generally avoid alprazolam. Elderly patients are at higher risk for falls and cognitive decline with benzodiazepines and may benefit from buspirone instead. Consult your healthcare provider to develop an anxiety treatment plan that considers both efficacy and safety.